Search

You searched for "fellows"

647 results found

A time management guide for urologists

1 July 2016 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Good time management is thought to not only reduce stress, but to improve personal efficiency, service delivery, clinical effectiveness and patient care. It was Benjamin Franklin in the 18th Century who originally made the link between success and the proper...

In conversation with Tim O’Brien

1 December 2020 | URO - Core Urology
We were delighted to catch up with Tim O’Brien, President of BAUS, about his career highlights and plans for the association. Can you tell us a little bit about what led you into the field of urology and the highlights...

In conversation with Sarika Nalagatla

29 June 2023 | | URO - Core Urology
We were delighted to catch up with Sarika Nalagatla, new Chair of the BAUS Section of Trainees (BSoT) about her life as a trainee urologist and plans for the association. Can you tell us a little bit about what led...

In conversation with Paula Allchorne

10 March 2022 | URO - Core Urology
We were delighted to catch up with Paula Allchorne, Chair of the European Association of Urology Nurses (EAUN) about her career in urological nursing and her plans for the association. Can you tell us a little bit about what led...
Urology journal cover image.

PDE5I in LUTS – how do they work – no proof yet

1 September 2014 | | URO - Basic Science Research, URO - Endourology & Stones, URO - Functional / Reconstructive Urology
Phosphodiesterase type 5 (PDE5) inhibitors used in erectile dysfunction (ED) have been shown to improve lower urinary tract symptoms (LUTS) as well. The mechanism is not well understood. One of the hypotheses for benign prostatic hyperplasia (BPH) – LUTS is...
European Urology journal front cover.

Prostate cancer detection in younger men

7 January 2026 | | URO - Urologic Oncology
Prostate cancer (PC) screening using prostate-specific antigen (PSA) testing with systematic biopsy (SBx) reduces mortality but risks overdiagnosis and unnecessary biopsies. Multiparametric MRI (mpMRI) enables MRI-targeted biopsy (TBx) of suspicious lesions and is now recommended before biopsy, although its role...

Immunotherapy in renal cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Renal cell carcinoma (RCC) is the sixth most common solid organ cancer in the UK. In 2018, there were 403,262 people diagnosed worldwide with the disease (2.2% of all cancer cases), and it accounted for 175,098 deaths in total (1.8%...

Redundant! Do urological surgeons have a future in treating urological cancers? RSM Urology Section Meeting

4 March 2024 | | URO - Urologic Oncology
December 2023 marked the latest RSM Urology Section event. Alongside the Winter Short Papers Prize presentations, the theme of the day was major urological cancers and the role of the urologist in patient management within the multidisciplinary team (MDT). We...

In conversation with James Green

3 October 2023 | URO - Core Urology
We were delighted to catch up with James Green, Consultant Urological Surgeon and new President of the Royal Society of Medicine Section of Urology. Can you tell us a little bit about what led you into the field of urology...

Convatec Healthcare is changing

11 May 2023
Forever Caring At Convatec, ‘forever caring’ is our promise to give patients and healthcare providers the support they need as we bring to life our vision of pioneering trusted medical solutions to improve the lives we touch. Existing complications of...

Keeping your eye on the ball: atypical presentations of testicular malignancy

4 March 2025 | | URO - Urologic Oncology
Most testicular cancers present with a painless lump on the testes, and most are confidently diagnosed on examination and ultrasound. They have an excellent prognosis, with 90% patients alive at 10 years [1]. However, advanced testicular cancer, or those with...

First-of-its-kind international study launches to revolutionise quality of life for Black men with prostate cancer

24 August 2026
BALANCE will generate pioneering evidence to fill gaps in our understanding of the challenges Black men face with prostate cancer and the support they need, making changes possible which will improve Black men's quality of life while navigating the disease....